Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
Autor: | Tomas L. Lindahl, Srinivas Uppugunduri, Kerstin Arbring |
---|---|
Rok vydání: | 2013 |
Předmět: |
Male
Medicin och hälsovetenskap medicine.medical_specialty Cross-sectional study Medical and Health Sciences Health administration medicine Humans International Normalized Ratio Intensive care medicine Aged Sweden Prothrombin time Primary Health Care medicine.diagnostic_test business.industry Health Policy Public health Warfarin Anticoagulants Quality control Atrial fibrillation Community Health Centers medicine.disease Thrombosis Oral anticoagulants Treatment Venous thrombosis Cross-Sectional Studies Treatment Outcome Prothrombin Time Female Drug Monitoring business Research Article medicine.drug |
Zdroj: | BMC Health Services Research |
ISSN: | 1472-6963 |
DOI: | 10.1186/1472-6963-13-85 |
Popis: | Background Oral anticoagulant therapy is used to prevent thrombosis in patients with atrial fibrillation (AF), venous thrombosis and prosthetic heart valves. The introduction of new therapies emphasizes the need to discern the best practice for the patients remaining on warfarin treatment. This study compares patient characteristics and therapeutic control in two settings managing warfarin treatment: Swedish primary health care centers (PHCC) and specialized anticoagulation clinics (ACC). Methods Prothrombin time (PT) test results reported as International Normalized Ratio (INR) were collected for five consecutive days from patients on warfarin treatment; 564 PHCC and 927 ACC patients. Therapeutic control was calculated as PT test results in relation to intended therapeutic range (TR). Mann–Whitney Rank Sum Test and Chi2 test were used for statistical comparisons. Results The PHCC patients were older than the ACC patients, 76 v. 70 years (pFunding Agencies|Medical Research Council of Southeast Sweden (FORSS) |
Databáze: | OpenAIRE |
Externí odkaz: |